Ladenburg Thalmann Financial Services’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q2
Sell
-34
Closed -$3K 4899
2015
Q1
$3K Buy
34
+14
+70% +$1.24K ﹤0.01% 4236
2014
Q4
$2K Buy
20
+8
+67% +$800 ﹤0.01% 4146
2014
Q3
$1K Sell
12
-7
-37% -$583 ﹤0.01% 3884
2014
Q2
$2K Buy
+19
New +$2K ﹤0.01% 3715